Clinical characteristics of PCDH19-female limited epilepsy
10.3760/cma.j.issn.0578-1310.2019.11.008
- VernacularTitle: PCDH19基因变异导致女性癫痫患儿的临床特点
- Author:
Yi CHEN
1
;
Xiaoling YANG
1
;
Aijie LIU
1
;
Dan SUN
2
;
Ying YANG
1
;
Jing ZHANG
1
;
Jiaoyang CHEN
1
;
Zhixian YANG
1
;
Yuwu JIANG
1
;
Xiru WU
1
;
Yuehua ZHANG
1
Author Information
1. Department of Pediatrics, Peking University First Hospital, Beijing 100034, China
2. Department of Neurology, Wuhan Children′s Hospital, Wuhan 430016, China
- Publication Type:Journal Article
- Keywords:
Epilepsy;
Prognosis;
Female;
Focal seizure;
Genes, PCDH19
- From:
Chinese Journal of Pediatrics
2019;57(11):857-862
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the clinical characteristics of patients with PCDH19-female limited epilepsy (PCDH19-FE).
Methods:The clinical data of 60 female epilepsy patients with PCDH19 gene heterozygous variations at the Department of Pediatrics, Peking University First Hospital from October 2007 to December 2018 were collected and analyzed retrospectively, their clinical manifestations, accessory examination and follow-up treatment were summarized.
Results:Data of a total of 60 cases of PCDH19-FE were collected. The seizure onset occurred between 4 and 42 months of age (median: 11 months of age). Focal seizures occurred in 47 patients (78%), generalized tonic-clonic seizures (GTCS) occurred in 30 patients (50%), and other rare types of seizures included atypical absence, myoclonic, clonic, tonic, and atonic seizures. Two or more seizures types existed in 24 patients (40%), and seven patients (12%) had attacks of status epilepticus. Sensitivity to fever was observed in 47 out of them (78%) and clustering of seizures as found in all patients. During the interictal phase, focal discharges were monitored in 22 cases (22/45, 49%), multifocal discharges in 12 cases (12/45, 27%), widely discharging in 2 cases (4%), and both focal and widely discharging in 9 cases (20%). Clinical seizures were detected in 30 patients during the electroencephalogram (EEG) recording, including focal seizures in 22 cases, GTCS seizures in 8 cases, tonic seizure in three cases, myoclonic seizure followed by GTCS in one case, and two types of seizures in four cases. Before seizure onset, 57 patients had normal development and three patients had delayed language development. After seizure onset, varied degrees of intelligence disability were present in 38 cases (63%), language delay in 36 cases (60%), and gait instability in 10 cases (17%). Autistic features occurred in 17 cases (28%); and other behavioral problems like learning difficulties, personality, or emotional disorders existed in 33 cases (55%). Age at last follow-up ranged from one year and 3 months to 22 years and 3 months of age, 17 patients (28%) were seizure-free for more than 2 years (5 to 22 years at the last follow-up). The efficiency of antiepileptic drugs were 65% (33/51) in sodium valproate, 63% (27/43) in levetiracetam and 59% (20/34) in topiramate.
Conclusions:The clinical features of PCDH19-FE are characterized by clustering of seizures, focal seizures in most cases, sensitivity to fever mostly, focal discharges principally in EEG, varied degrees of intellectual disability or movement disorder, combined with autism spectrum disorders in partial and high efficiency in sodium valproate or levetiracetam treatment.
